Statements of Operations - USD ($) |
3 Months Ended | 6 Months Ended | 12 Months Ended | |||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Mar. 31, 2026 |
Mar. 31, 2025 |
Mar. 31, 2026 |
Mar. 31, 2025 |
Dec. 31, 2025 |
Sep. 30, 2025 |
Dec. 31, 2024 |
Sep. 30, 2024 |
|||||||||
| Operating expenses | ||||||||||||||||
| General and administrative expenses | $ 748,177 | $ 163,485 | $ 928,177 | $ 339,926 | $ 748,908 | $ 523,974 | ||||||||||
| Loss from operations | (748,177) | (163,485) | (928,177) | (339,926) | (748,908) | (523,974) | ||||||||||
| Other income: | ||||||||||||||||
| Net profit/(loss) before income tax expense | (611,075) | 1,086,656 | (637,786) | 2,281,745 | 4,381,804 | 2,502,899 | ||||||||||
| Interest and dividends earned on cash and investments held in Trust Account | 137,102 | 1,250,141 | 290,391 | 2,621,671 | 5,130,712 | 3,026,873 | ||||||||||
| Other income | 137,102 | 1,250,141 | 290,391 | 2,621,671 | 5,130,712 | 3,026,873 | ||||||||||
| Provision for income taxes | (28,791) | (262,530) | (60,982) | (550,551) | (965,635) | (635,512) | ||||||||||
| Net income | (639,866) | 824,126 | $ (698,768) | $ 1,731,194 | $ 3,416,169 | $ 1,867,387 | ||||||||||
| GNQ INSILICO INC [Member] | ||||||||||||||||
| Revenue (Note 13) | 250,000 | |||||||||||||||
| Operating expenses | ||||||||||||||||
| Cost of revenue | (139,470) | |||||||||||||||
| Compensation expense | (80,567) | (483) | (60,631) | |||||||||||||
| Professional and consulting fees | (1,214,836) | (149,573) | (1,460,928) | (741,414) | ||||||||||||
| Share Compensation (Note 14) | (34,297) | (44,053) | (3,449,212) | |||||||||||||
| Research and development (Note 16) | (200,254) | (39,831) | (347,933) | (687,492) | ||||||||||||
| Business development | (9,921) | (18,224) | (35,964) | (21,780) | ||||||||||||
| Sales and marketing expense | (9,500) | |||||||||||||||
| Administrative and management fee | (15,000) | (15,000) | (60,000) | (60,000) | ||||||||||||
| General, administrative and other expenses | (88,454) | (12,800) | (99,338) | (7,036) | ||||||||||||
| Depreciation and amortization | (424) | (71) | (70,896) | |||||||||||||
| Loss before other expenses and income tax expense | (1,542,723) | (235,982) | (2,179,743) | (4,966,934) | ||||||||||||
| Other income: | ||||||||||||||||
| Foreign exchange loss | (85) | 170 | (599) | (12,295) | ||||||||||||
| Bank charges | (390) | (533) | ||||||||||||||
| Interest expense | (1,001) | (147) | ||||||||||||||
| Gain/(loss) on fair value of investment (Note 20) | 27,373 | (168,965) | (393,618) | (1,361,481) | ||||||||||||
| Gain/(loss) on fair value of debt instrument (Note 11) | (15,022) | |||||||||||||||
| Net profit/(loss) before income tax expense | (1,531,458) | (404,924) | (2,574,350) | (6,341,243) | ||||||||||||
| Provision for income taxes | ||||||||||||||||
| Net income | $ (1,531,458) | $ (404,924) | $ (2,574,350) | $ (6,341,243) | ||||||||||||
| Weighted-average common shares outstanding, basic | 26,939,850 | [1] | 21,351,250 | [1] | 22,603,000 | [2] | 17,322,917 | |||||||||
| Net loss per common share, basic | $ (0.06) | $ (0.02) | $ (0.11) | $ (0.37) | ||||||||||||
| Weighted-average common shares outstanding, diluted | 26,939,850 | [1] | 21,351,250 | [1] | 22,603,000 | [2] | 17,322,917 | [2] | ||||||||
| Net loss per common share, diluted | $ (0.06) | $ (0.02) | $ (0.11) | $ (0.37) | ||||||||||||
| Redeemable Common Stock [Member] | ||||||||||||||||
| Other income: | ||||||||||||||||
| Weighted-average common shares outstanding, basic | 1,442,097 | 11,500,000 | 1,466,757 | 11,500,000 | 11,253,200 | 5,860,274 | ||||||||||
| Net loss per common share, basic | $ (0.11) | $ 0.05 | $ (0.12) | $ 0.11 | $ 0.22 | $ 0.20 | ||||||||||
| Weighted-average common shares outstanding, diluted | 1,442,097 | 11,500,000 | 1,466,757 | 11,500,000 | 11,253,200 | 5,860,274 | ||||||||||
| Net loss per common share, diluted | $ (0.11) | $ 0.05 | $ (0.12) | $ 0.11 | $ 0.22 | $ 0.19 | ||||||||||
| Nonredeemable Common Stock [Member] | ||||||||||||||||
| Other income: | ||||||||||||||||
| Weighted-average common shares outstanding, basic | 4,249,090 | 4,249,090 | 4,249,090 | 4,249,090 | 4,249,090 | 3,548,500 | ||||||||||
| Net loss per common share, basic | $ (0.11) | $ 0.05 | $ (0.12) | $ 0.11 | $ 0.22 | $ 0.20 | ||||||||||
| Weighted-average common shares outstanding, diluted | 4,249,090 | 4,249,090 | 4,249,090 | 4,249,090 | 4,249,090 | 3,755,982 | ||||||||||
| Net loss per common share, diluted | $ (0.11) | $ 0.05 | $ (0.12) | $ 0.11 | $ 0.22 | $ 0.19 | ||||||||||
| ||||||||||||||||
| X | ||||||||||
- Definition Administrative and management fee. No definition available.
|
| X | ||||||||||
- Definition Bank charges. No definition available.
|
| X | ||||||||||
- Definition Compensation expense. No definition available.
|
| X | ||||||||||
- Definition Interest and dividends earned on cash and investments held in trust account. No definition available.
|
| X | ||||||||||
- Definition Business development involves the development of products and services, their delivery, design and their implementation. Business development includes a number of techniques designed to grow an economic enterprise. Such techniques include, but are not limited to, assessments of marketing opportunities and target markets, intelligence gathering on customers and competitors, generating leads for possible sales, follow-up sales activity, formal proposal writing and business model design. Business development involves evaluating a business and then realizing its full potential, using such tools as marketing, sales, information management and customer service. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- Definition The current period expense charged against earnings on long-lived, physical assets not used in production, and which are not intended for resale, to allocate or recognize the cost of such assets over their useful lives; or to record the reduction in book value of an intangible asset over the benefit period of such asset; or to reflect consumption during the period of an asset that is not used in production. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Amount of unrealized and realized gain (loss) on investment in equity security measured at fair value with change in fair value recognized in net income (FV-NI). Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition The net gain (loss) resulting from a sale of loans, including adjustments to record loans classified as held-for-sale at the lower-of-cost-or-market and fair value adjustments to loan held for investment purposes. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition The aggregate total of expenses of managing and administering the affairs of an entity, including affiliates of the reporting entity, which are not directly or indirectly associated with the manufacture, sale or creation of a product or product line. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
| X | ||||||||||
- Definition Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Amount of interest expense classified as operating and nonoperating. Includes, but is not limited to, cost of borrowing accounted for as interest expense. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition The portion of profit or loss for the period, net of income taxes, which is attributable to the parent. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business). Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- Definition Generally recurring costs associated with normal operations except for the portion of these expenses which can be clearly related to production and included in cost of sales or services. Excludes Selling, General and Administrative Expense. No definition available.
|
| X | ||||||||||
- Definition Generally recurring costs associated with normal operations except for the portion of these expenses which can be clearly related to production and included in cost of sales or services. Includes selling, general and administrative expense. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
| X | ||||||||||
- Definition The net result for the period of deducting operating expenses from operating revenues. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
| X | ||||||||||
- Definition Amount of selling, general and administrative expense classified as other. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition A fee charged for services from professionals such as doctors, lawyers and accountants. The term is often expanded to include other professions, for example, pharmacists charging to maintain a medicinal profile of a client or customer. Reference 1: http://www.xbrl.org/2003/role/exampleRef
|
| X | ||||||||||
- Definition Amount of expense for research and development. Includes, but is not limited to, cost for computer software product to be sold, leased, or otherwise marketed and writeoff of research and development assets acquired in transaction other than business combination or joint venture formation or both. Excludes write-down of intangible asset acquired in business combination or from joint venture formation or both, used in research and development activity. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition The aggregate total amount of expenses directly related to the marketing or selling of products or services. No definition available.
|
| X | ||||||||||
- Definition Amount of noncash expense for share-based payment arrangement. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Amount of net unrealized gain (loss) related to the change in fair value of foreign currency exchange rate derivatives designated as cash flow hedging instruments. Recorded in accumulated other comprehensive income to the extent that the cash flow hedge is determined to be effective. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
| X | ||||||||||
- Definition The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|